Form 4: Cigna Director George Kurian Reports Acquisition of Phantom Stock Units

Director George Kurian reported the acquisition of phantom stock units in The Cigna Group through a deferred compensation plan.

Summary

• On February 29, 2024, George Kurian, a director of The Cigna Group, reported the acquisition of 89.2485 phantom stock units.
• These units were acquired under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation.
• The phantom stock units represent the voluntary deferral of a portion of the director's cash retainer into a hypothetical stock fund.
• Each phantom stock unit is economically equivalent to one share of The Cigna Group's common stock and will be settled in cash.
• The reporting person also owns 3.7173 phantom stock units acquired through a dividend reinvestment feature of the Deferral Plan, bringing the total to 991.2836 units.
• A power of attorney was executed on January 23, 2024, designating several individuals to act on behalf of George Kurian for SEC filings.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, indicating a stable and ongoing relationship between the director and the company. The use of deferred compensation plans is generally viewed positively as it aligns management interests with shareholder value.

Positives

• The acquisition of phantom stock units reflects the director's continued investment in the company's future.
• The Deferred Compensation Plan allows directors to align their interests with those of shareholders.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the financial interests of company directors.

Comparison to Industry Standards

• Deferred compensation plans are a common practice among publicly traded companies to attract and retain directors.
• Phantom stock units are often used as a form of deferred compensation, aligning directors' interests with shareholder value.
• Companies like UnitedHealth Group and Anthem (now Elevance Health) also utilize similar compensation strategies for their executives and directors.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency to shareholders regarding director compensation and ownership.

Key Dates